UBS analyst Fumiyoshi Sakai downgraded Sumitomo Pharma (4506:JP) (OTC: DNPUF) from Neutral to Sell with a price target of JPY370.00.The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE